Save information for later
Sign Up

Learn About Lymphomatoid Papulosis

What is the definition of Lymphomatoid Papulosis?
Lymphomatoid papulosis (LyP) is a non-contagious, chronic skin condition characterized by the eruption of recurring, self-healing bumps (lesions) on the skin. The lesions typically begin small and then become larger, and they may bleed or ulcerate before becoming scaly and crusty. They often develop a red-brown color. Symptoms associated with lesions may include itching and/or pain, which may be debilitating. The frequency of eruptions varies over time and from person to person. Lesions may be very persistent, or they may go away for long periods of time before coming back. They may occur anywhere on the body, but they typically develop on the trunk, arms, and legs, and may develop on the hands, face, and genitalia. They generally go away on their own over a period of weeks to months (usually between 3 and 8 weeks), with or without scarring. LyP is not contagious. The cause of LyP is not known, but there is no evidence that it is hereditary. Stress is often reported to trigger eruptions of lesions. A diagnosis of LyP requires evaluating the symptoms and having a skin biopsy for various types of laboratory tests. While LyP usually is not classified as a cancer (although there has been some debate), it has characteristics of lymphoma under the microscope, and people with LyP have a life-long increased risk of developing lymphoma such as mycosis fungoides, PC-ALCL, or Hodgkin lymphoma. In 5 to 20 percent of people with LyP, the condition is either preceded by lymphoma, associated with lymphoma, or followed by lymphoma. When LyP is diagnosed it is important to rule out these cancers, and for this reason, various blood tests or imaging studies may also be recommended.
What are the alternative names for Lymphomatoid Papulosis?
  • Lymphomatoid papulosis
  • LyP
Who are the top Lymphomatoid Papulosis Local Doctors?
Experienced in Lymphomatoid Papulosis
Hematology Oncology | Hematology | Oncology
Experienced in Lymphomatoid Papulosis
Hematology Oncology | Hematology | Oncology

Good Samaritan Hospital Physician Services Inc

520 S 7th St, 
Vincennes, IN 
 (19.5 mi)
Languages Spoken:
English
Accepting New Patients

Karim Anwar is a Hematologist Oncology specialist and a Hematologist in Vincennes, Indiana. Dr. Anwar and is rated as an Experienced provider by MediFind in the treatment of Lymphomatoid Papulosis. His top areas of expertise are Familial Colorectal Cancer, Lynch Syndrome, Colorectal Cancer, and Lung Adenocarcinoma. Dr. Anwar is currently accepting new patients.

Distinguished in Lymphomatoid Papulosis
Oncology | Hematology Oncology | Hematology
Distinguished in Lymphomatoid Papulosis
Oncology | Hematology Oncology | Hematology

University Medical Diagnostic Associates Inc

550 N University Blvd, 
Indianapolis, IN 
 (93.8 mi)
Languages Spoken:
English
Accepting New Patients

Michael Robertson is an Oncologist and a Hematologist Oncology provider in Indianapolis, Indiana. Dr. Robertson and is rated as a Distinguished provider by MediFind in the treatment of Lymphomatoid Papulosis. His top areas of expertise are Marginal Zone Lymphoma (MZL), Follicular Lymphoma, Primary Lymphoma of the Brain, Diffuse Large B-Cell Lymphoma (DLBCL), and Bone Marrow Transplant. Dr. Robertson is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Distinguished in Lymphomatoid Papulosis
Distinguished in Lymphomatoid Papulosis

Iu Health Medical Group LLC

1701 N Senate Blvd, 
Indianapolis, IN 
 (95.0 mi)
Languages Spoken:
English
Accepting New Patients

Lawrence Mark is a Dermatologist in Indianapolis, Indiana. Dr. Mark and is rated as a Distinguished provider by MediFind in the treatment of Lymphomatoid Papulosis. His top areas of expertise are T-Cell Lymphoma, Lymphomatoid Papulosis, Mycosis Fungoides, and Anaplastic Large Cell Lymphoma. Dr. Mark is currently accepting new patients.

What are the latest Lymphomatoid Papulosis Clinical Trials?
A Tissue Repository for the Collection of Samples From Patients With Cutaneous T Cell Lymphoma and Healthy Volunteers

Summary: This document is a protocol for a non-interventional human research study in which the investigator hopes to better understand the changes that take place in T cells in Cutaneous T-cell lymphoma (CTCL). The purpose of this study is to establish a protocol for the collection and storage of tissue samples from patients with CTCL for future research studies. Collection and storage of tissue samples f...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Optimizing Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome, and Lymphomatoid Papulosis

Summary: The purpose of this study is to test any good and bad effects of the study drug called brentuximab vedotin at a lower dose than is FDA-approved.

Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center